The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | S | Sensory organs | |
| 2 | S01 | Ophthalmologicals | |
| 3 | S01F | Mydriatics and cycloplegics | |
| 4 | S01FA | Anticholinergics | |
| 5 | S01FA01 | Atropine |
| Active Ingredient | Description | |
|---|---|---|
| Atropine |
Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ATROPINE Eye drops | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ATROPINE Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ATROPINE Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ISOPTO ATROPINE Ophthalmic solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
